In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mupirocin, Calcium Salt (2:1) Drug Master File in Korea (Mupirocin, Calcium Salt (2:1) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mupirocin, Calcium Salt (2:1). The MFDS reviews the Mupirocin, Calcium Salt (2:1) KDMF as part of the drug registration process and uses the information provided in the Mupirocin, Calcium Salt (2:1) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mupirocin, Calcium Salt (2:1) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mupirocin, Calcium Salt (2:1) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mupirocin, Calcium Salt (2:1) suppliers with KDMF on PharmaCompass.